C39H65N5O8
Neat
731.98
+5°C
Room Temperature
MMAF; 745017-94-1; Monomethyl Auristatin F; Monomethylauristatin F; DTXSID601031563; 1Z1AI9IW5L; MMAF peptide; RefChem:926092; DTXCID201516583; MFCD25976742; MMAF (GMP); (2S)-2-[[(2R, 3R)-3-methoxy-3-[(2S)-1-[(3R, 4S, 5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoic acid; (S)-2-((2R, 3R)-3-((S)-1-((3R, 4S, 5S)-4-((S)-N, 3-Dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoic acid; MONOMETHYLAURISTATIN PHENYLALANINE; ((2R, 3R)-3-((S)-1-((3R, 4S, 5S)-4-((S)-N, 3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine; C39H65N5O8; (2S)-2-[(2R)-2-[(R)-[(2S)-1-[(3R, 4S, 5S)-4-[(2S)-N, 3-dimethyl-2-[(2S)-3-methyl-2-(methylamino)butanamido]butanamido]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl](methoxy)methyl]propanamido]-3-phenylpropanoic acid; N-Methyl-L-valyl-L-valyl-(3R, 4S, 5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(aR, ssR and 2S)-ss-methoxy-a-methyl-2-pyrrolidinepropanoyl-L-phenylalanine; MMAF;; MonomethylauristatinF; SCHEMBL3208014
(2S)-2-[[(2R, 3R)-3-methoxy-3-[(2S)-1-[(3R, 4S and 5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoic acid
InChI=1S/C39H65N5O8/c1-12-25(6)34(43(9)38(48)33(24(4)5)42-37(47)32(40-8)23(2)3)30(51-10)22-31(45)44-20-16-19-29(44)35(52-11)26(7)36(46)41-28(39(49)50)21-27-17-14-13-15-18-27/h13-15,17-18,23-26,28-30,32-35,40H,12,16,19-22H2,1-11H3,(H,41,46)(H,42,47)(H,49,50)/t25-,26+,28-,29-,30+,32-,33-,34-,35+/m0/s1